Efficacy And Safety Of Examethasone, High Dose Cytarabine, And Carboplatin (Dhac) With And Without Rituximab (R) As A Salvage Regimen For Relapsed/Refractory (R/R) Lymphoma.

Jeffrey Baron, Megan Menon,Ryan Hare,Ian Lund,Alice Mohr,Cherie Rondeau,Margaret Syta,Kimberly Celotto,Swaminathan Padmanabhan Iyer,Seema Bhat,Francisco J. Hernandez-Ilizaliturri

JOURNAL OF CLINICAL ONCOLOGY（2016）

引用 0|浏览11

暂无评分

摘要

e19023Background: Adequate cytoreduction with cisplatin-based chemotherapy is commonly used prior to high dose chemotherapy and autologous stem cell support (HDC-ASCS) among R/R aggressive lymphoma...

查看译文

关键词

high dose cytarabine,lymphoma,rituximab,carboplatin,dhac

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要